Cargando…

AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study

The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study...

Descripción completa

Detalles Bibliográficos
Autores principales: Concha, Josef Symon S., Merola, Joseph F., Fiorentino, David, Dutz, Jan Peter, Goodfield, Mark, Nyberg, Filippa, Volc-Platzer, Beatrix, Fujimoto, Manubo, Ang, Chia Chun, Werth, Victoria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033393/
http://dx.doi.org/10.21037/atm.2021.AB014
_version_ 1783676405323661312
author Concha, Josef Symon S.
Merola, Joseph F.
Fiorentino, David
Dutz, Jan Peter
Goodfield, Mark
Nyberg, Filippa
Volc-Platzer, Beatrix
Fujimoto, Manubo
Ang, Chia Chun
Werth, Victoria P.
author_facet Concha, Josef Symon S.
Merola, Joseph F.
Fiorentino, David
Dutz, Jan Peter
Goodfield, Mark
Nyberg, Filippa
Volc-Platzer, Beatrix
Fujimoto, Manubo
Ang, Chia Chun
Werth, Victoria P.
author_sort Concha, Josef Symon S.
collection PubMed
description The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study to create a combination of items that will define a more inclusive cohort of DM patients with skin-predominant disease for clinical research. Several measurement properties that need to be assessed prior to the conduct of a multicenter prospective validation study include the final purpose of the criteria set, population and disease characteristics of cases and controls for study entry, sources of samples, definition of criteria items, methods of item ranking and reduction, and consideration of criteria set validity against a comparator backdrop “gold standard” criteria. An expert committee Delphi and several online discussions among participants from the fields of dermatology, and adult and pediatric rheumatology have been conducted in order to address such issues. Constant evaluation of the methodologic process is vital to produce classification criteria which are valid and reliable to identify patients with DM and delineate these patients from those with mimicker diseases.
format Online
Article
Text
id pubmed-8033393
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-80333932021-04-09 AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study Concha, Josef Symon S. Merola, Joseph F. Fiorentino, David Dutz, Jan Peter Goodfield, Mark Nyberg, Filippa Volc-Platzer, Beatrix Fujimoto, Manubo Ang, Chia Chun Werth, Victoria P. Ann Transl Med Abstract on Rheumatologic Skin Disease The Dermatomyositis Delphi Criteria Project created 25 provisional clinical, laboratory and contextual classification criteria after an extensive literature search, three rounds of consensus exercises and nominal group discussions. These criteria will be subjected to a case-control validation study to create a combination of items that will define a more inclusive cohort of DM patients with skin-predominant disease for clinical research. Several measurement properties that need to be assessed prior to the conduct of a multicenter prospective validation study include the final purpose of the criteria set, population and disease characteristics of cases and controls for study entry, sources of samples, definition of criteria items, methods of item ranking and reduction, and consideration of criteria set validity against a comparator backdrop “gold standard” criteria. An expert committee Delphi and several online discussions among participants from the fields of dermatology, and adult and pediatric rheumatology have been conducted in order to address such issues. Constant evaluation of the methodologic process is vital to produce classification criteria which are valid and reliable to identify patients with DM and delineate these patients from those with mimicker diseases. AME Publishing Company 2021-03 /pmc/articles/PMC8033393/ http://dx.doi.org/10.21037/atm.2021.AB014 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Abstract on Rheumatologic Skin Disease
Concha, Josef Symon S.
Merola, Joseph F.
Fiorentino, David
Dutz, Jan Peter
Goodfield, Mark
Nyberg, Filippa
Volc-Platzer, Beatrix
Fujimoto, Manubo
Ang, Chia Chun
Werth, Victoria P.
AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title_full AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title_fullStr AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title_full_unstemmed AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title_short AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
title_sort ab014. developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
topic Abstract on Rheumatologic Skin Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033393/
http://dx.doi.org/10.21037/atm.2021.AB014
work_keys_str_mv AT conchajosefsymons ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT merolajosephf ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT fiorentinodavid ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT dutzjanpeter ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT goodfieldmark ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT nybergfilippa ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT volcplatzerbeatrix ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT fujimotomanubo ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT angchiachun ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy
AT werthvictoriap ab014developingclassificationcriteriaforskinpredominantdermatomyositisassessingthemethodologyoftheprospectivevalidationstudy